Imeglimin Population Pharmacokinetics and Dose Adjustment Predictions for Renal Impairment in Japanese and Western Patients with Type 2 Diabetes

Clin Transl Sci. 2022 Apr;15(4):1014-1026.
Tomita Y, Hansson E, Mazuir F, Wellhagen G, Ooi QX, Mezzalana E, Kitamura A, Nemoto D, Bolze S.
EndocrinologyJournalMetabolismMIDDPharmacometricsRenal diseasesSpecial/specific populations

Pharmetheus Affiliates

Portrait-of-Emma-Hansson_Pharmetheus
Senior Director, Regulatory Affairs

Emma Hansson

See bio
Portrait-of-Qing-Xi-Ooi-Pharmetheus
Senior Director, MIDD Consultant

Qing Xi Ooi

See bio
Portrait-of-Enrica-Mezzalana_Pharmetheus-1
Senior Director, MIDD Consultant

Enrica Mezzalana

See bio